About the Company
We do not have any company description for SUPERNUS PHARMACEUTICALS, INC. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $SUPN News
Supernus Pharmaceuticals, Inc. (SUPN)
On Monday, Supernus Pharmaceuticals Inc. (NASDAQ:SUPN) announced a regulatory update for SPN-830, an investigational apomorphine infusion device under FDA review for the continuous treatment of ...
Supernus Pharmaceuticals gets grant for patent granted for compound of formula ii for CNS disorders
Discover Supernus Pharmaceuticals Inc's groundbreaking patent for a versatile compound aimed at treating central nervous system disorders. Learn about the innovative formula, derivatives, and ...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN
New York, New York-- (Newsfile Corp. - April 22, 2024) - Pomerantz LLP is investigating claims on behalf of investors of Supernus Pharmaceuticals, Inc. ("Supernus" or the "Company") (NASDAQ: SUPN).
Supernus Pharmaceuticals Faces Second FDA Rejection For Investigational Device For Parkinson's Disease
On Monday, Supernus Pharmaceuticals Inc. (NASDAQ:SUPN) announced a regulatory update for SPN-830, an investigational apomorphine infusion device under FDA review for the continuous treatment of ...
Supernus Provides Regulatory Update for SPN-830
ROCKVILLE, Md., April 08, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment ...
Supernus: Q4 Earnings Snapshot
ROCKVILLE, Md. (AP) — ROCKVILLE, Md. (AP) — Supernus Pharmaceuticals Inc. (SUPN) on Tuesday reported profit of $1.2 million in its fourth quarter. The Rockville, Maryland-based company said it ...
Supernus Pharmaceuticals, Inc.: Supernus Provides Regulatory Update for SPN-830
Supernus Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases. Our diverse ...
Supernus Pharmaceuticals Inc SUPN
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Supernus Pharmaceuticals, Inc. (SUPN)
Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...
Loading the latest forecasts...